Who owns Arrowhead Pharmaceuticals In call?

Tip: Access positions for across all investors

Analyze quarterly positions in Arrowhead Pharmaceuticals In call with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Arrowhead Pharmaceuticals In call stock

Who bought or sold Arrowhead Pharmaceuticals In call this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
IMC-Chicago 73k $4.8M 4% Sep 2026
 View chart
Group One Trading 71k $5.8M 10% Jun 2026
 View chart
Simplex Trading 43k $2.8M 36% Sep 2026
 View chart
Hrt Financial 12k $937k 16% Jun 2026
 View chart
Timothy G. Youngquist 2020 Irrevocable Trust 6.0k $42k 100% Sep 2026
 View chart